BI
PTLA

BVF Inc’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BVF Inc’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-305,786
Closed -$7.51M – 29
2013
Q2 		$7.51M Buy
+305,786
New +$6.08M 1.46% 13

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BVF Inc's PTLA Position: Q3 2013 in Review

BVF Inc sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2013, closing a stake of 305,786 shares — an estimated $7.51M sold.

BVF Inc first reported a position in PTLA in Q2 2013 and held it in 1 quarter. The position peaked at $7.51M in Q2 2013. 69 funds tracked by Wall St. Rank hold PTLA as of Q3 2013.

  • BVF Inc reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • BVF Inc sold 305,786 Portola Pharmaceuticals, Inc. shares in Q3 2013, an estimated $7.51M.
  • BVF Inc first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • BVF Inc's Portola Pharmaceuticals, Inc. position peaked at $7.51M in Q2 2013.
  • 69 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2013.

Based on BVF Inc's 13F filing for Q3 2013, filed 14 Nov 2013.